BriaCell Therapeutics Corp. Share Price
BCTXBriaCell Therapeutics Corp. Stock Performance
Open $3.06 | Prev. Close $3.15 | Circuit Range N/A |
Day Range $2.96 - $3.09 | Year Range $0.61 - $13.78 | Volume 1,644 |
Average Traded $3.05 |
BriaCell Therapeutics Corp. Share Price Chart
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
BriaCell Therapeutics Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Jun-26 | $3.06 | $2.96 | +0.00% |
09-Jun-26 | $3.06 | $2.96 | -5.87% |
08-Jun-26 | $3.15 | $3.15 | +2.27% |
05-Jun-26 | $3.13 | $3.08 | -5.23% |
04-Jun-26 | $3.27 | $3.25 | -3.13% |
03-Jun-26 | $3.20 | $3.35 | +2.60% |
02-Jun-26 | $3.27 | $3.27 | -0.61% |